Gene · 3732
Papers4,224
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 4,224
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A universal glycoenzyme biosynthesis pipeline that enables efficient cell-free remodeling of glycans. | Nat Commun | 2022 | 36280670 | PubTator, text mining | PubMed |
| The evolving role of extracellular vesicles (exosomes) as biomarkers in traumatic brain injury: Clinical perspectives and therapeutic implications. | Front Aging Neurosci | 2022 | 36275010 | PubTator, text mining | PubMed |
| Discovery of Muscle-Tendon Progenitor Subpopulation in Human Myotendinous Junction at Single-Cell Resolution. | Research (Wash D C) | 2022 | 36267539 | PubTator, text mining | PubMed |
| Maternal blood pressure associates with placental DNA methylation both directly and through alterations in cell-type composition. | BMC Med | 2022 | 36266660 | PubTator, text mining | PubMed |
| Asymmetric Cyclopropanation with 4-Aryloxy-1-sulfonyl-1,2,3-triazoles: Expanding the Range of Rhodium-Stabilized Donor/Acceptor Carbenes to Systems with an Oxygen Donor Group. | J Org Chem | 2022 | 36264239 | PubTator, text mining | PubMed |
| Update on the application of mesenchymal stem cell-derived exosomes in the treatment of Parkinson's disease: A systematic review. | Front Neurol | 2022 | 36262830 | PubTator, text mining | PubMed |
| The Hybrid Multiple-Criteria Decision-Making Model for Home Healthcare Nurses' Job Satisfaction Evaluation and Improvement. | Int J Public Health | 2022 | 36250154 | PubTator, text mining | PubMed |
| Understanding the extracellular vesicle surface for clinical molecular biology. | J Extracell Vesicles | 2022 | 36239734 | PubTator, text mining | PubMed |
| Selective immunocapture reveals neoplastic human mast cells secrete distinct microvesicle- and exosome-like populations of KIT-containing extracellular vesicles. | J Extracell Vesicles | 2022 | 36239715 | PubTator, text mining | PubMed |
| A Low-Cost Multi-Purpose IoT Sensor for Biologging and Soundscape Activities. | Sensors (Basel) | 2022 | 36236203 | PubTator, text mining | PubMed |
| Update on Extracellular Vesicle-Based Vaccines and Therapeutics to Combat COVID-19. | Int J Mol Sci | 2022 | 36232549 | PubTator, text mining | PubMed |
| Pancreatic Cancer Cell-Derived Exosomes Promote Lymphangiogenesis by Downregulating ABHD11-AS1 Expression. | Cancers (Basel) | 2022 | 36230535 | PubTator, text mining | PubMed |
| Cancer-associated Fibroblasts Communicate with Breast Tumor Cells Through Extracellular Vesicles in Tumor Development. | Technol Cancer Res Treat | 2022 | 36222020 | PubTator, text mining | PubMed |
| Tetraspanin-5-mediated MHC class I clustering is required for optimal CD8 T cell activation. | Proc Natl Acad Sci U S A | 2022 | 36215490 | PubTator, text mining | PubMed |
| Extracellular vesicles: Emerging tools as therapeutic agent carriers. | Acta Pharm Sin B | 2022 | 36213541 | PubTator, text mining | PubMed |
| Literature-based translation from synthetic lethality screening into therapeutics targets: CD82 is a novel target for KRAS mutation in colon cancer. | Comput Struct Biotechnol J | 2022 | 36212540 | PubTator, text mining | PubMed |
Synthesis, spectroscopic, topological, hirshfeld surface analysis, and anti-covid-19 molecular docking investigation of isopropyl 1-benzoyl-4-(benzoyloxy)-2,6-diphenyl-1,2,5,6-tetrahydropyridine-3-carboxylate. | Heliyon | 2022 | 36211997 | PubTator, text mining | PubMed |
| OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications. | Front Immunol | 2022 | 36189271 | PubTator, text mining | PubMed |
| Isolation of a cytolytic subpopulation of extracellular vesicles derived from NK cells containing NKG7 and cytolytic proteins. | Front Immunol | 2022 | 36189227 | PubTator, text mining | PubMed |
| Small extracellular vesicles isolation and separation: Current techniques, pending questions and clinical applications. | Theranostics | 2022 | 36185597 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3732/papers?page=33